Filing Details
- Accession Number:
- 0001140361-16-084885
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-04 15:43:39
- Reporting Period:
- 2016-11-03
- Filing Date:
- 2016-11-04
- Accepted Time:
- 2016-11-04 15:43:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082038 | Durect Corp | DRRX | Pharmaceutical Preparations (2834) | 943297098 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1325447 | First Eagle Investment Management, Llc | 1345 Avenue Of The Americas 44Th Floor New York NY 10105 | No | No | Yes | No | |
1457518 | First Eagle Value In Biotechnology Master Fund, Ltd. | Citco Fund Services (Cayman Islands) Ltd Regatta Office Park West Bay Road Grand Cayman E9 KY1-1205 | No | No | Yes | No | |
1459688 | 21 April Fund, L.p. | First Eagle Investment Management, Llc 1345 Avenue Of The Americas, 44Th Floor New York NY 10105 | No | No | Yes | No | |
1459708 | 21 April Fund, Ltd. | Citco Fund Services (Cayman Islands) Ltd Regatta Office Park West Bay Road Grand Cayman E9 KY1-1205 | No | No | Yes | No | |
1637141 | First Eagle Holdings, Inc. | 1345 Avenue Of The Americas New York NY 10105 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-11-03 | 50,000 | $1.18 | 22,431,546 | No | 4 | P | Indirect | See Footnote |
Common Stock | Acquisiton | 2016-11-03 | 25,000 | $1.14 | 22,456,546 | No | 4 | P | Indirect | See Footnote |
Common Stock | Acquisiton | 2016-11-03 | 20,000 | $1.14 | 22,476,546 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
Footnotes
- This Form 4 is filed by 21 April Fund, LP ("April LP"), 21 April Ltd. ("April Ltd."), First Eagle Investment Management, LLC ("FEIM"), First Eagle Value in Biotechnology Master Fund, Ltd. ("FEVIBM") and First Eagle Holdings, Inc. ("FEHI" and, collectively with April LP, April Ltd., FEIM and FEVIBM, the "Entities"). The Entities disclaim status as a "group" for purposes of this Form 4.
- These shares are indirectly beneficially owned by certain separately managed accounts, including accounts for which FEIM serves as registered investment adviser (the "Separately Managed Accounts").
- The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) a general partner of April LP, (ii) the registered investment adviser to FEVIBM as well as to April LP and April Ltd. (collectively, the "Funds"), (iii) a subsidiary of FEHI and (iv) FEIM is investment adviser to certain of the Separately Managed Accounts. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
- Represents 3,426,893, 13,367,709, 5,586,944 and 50,000 shares held directly by 21 April LP, 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
- Represents 3,426,893, 13,367,709, 5,586,944 and 75,000 shares held directly by 21 April LP, 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
- Represents 3,426,893, 13,367,709, 5,586,944 and 95,000 shares held directly by 21 April LP, 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.